Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix and SAIC to Collaborate on Biothreat Microarray Technology Development

NEW YORK, Oct. 14 (GenomeWeb News) - CombiMatrix and Science Applications International today announced a collaboration to develop microarray technology for identification of biothreat organisms.

The companies will apply some of US Department of Defense funding they each have in hand for the collaboration, CombiMatrix said in a statement. Further financial details were not disclosed.

CombiMatrix,  the life-sciences division of Newport Beach, Calif.-based Acacia Research, will supply its microarray platform to the collaboration while San Diego-based SAIC, an information technology supplier, will apply its suite of genomic assays and data mining tools.


The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.